(Q79279426)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14610105%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

The measurement of antibodies binding to IFNbeta in MS patients treated with IFNbeta (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14610105%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

The measurement of antibodies binding to IFNβ in MS patients treated with IFNβ (English)

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000092359.93813.92

31 March 2024

3

Jacqueline Palace

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14610105%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Joel Oger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14610105%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Andrew R. Pachner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14610105

31 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14610105

31 March 2024

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14610105%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

11 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14610105

full work available at URL

31 March 2024

https://www.neurology.org/doi/pdfdirect/10.1212/01.WNL.0000092359.93813.92

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000092359.93813.92

31 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14610105%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14610105%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

9 Suppl 5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14610105%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

S18-20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14610105%20AND%20SRC:MED&resulttype=core&format=json

ELISA methods for the analysis of antibody responses induced in multiple sclerosis patients treated with recombinant interferon-beta

20 December 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000092359.93813.92

Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies

31 March 2024

2

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000092359.93813.92

The evolution of neutralizing antibodies in multiple sclerosis patients treated with interferon beta-1b

31 March 2024

3

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000092359.93813.92

An improved ELISA for screening for neutralizing anti-IFN-beta antibodies in MS patients

31 March 2024

4

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000092359.93813.92

Drug treatments for eye movement disorders

31 March 2024

5

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000092359.93813.92

31 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14610105%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference